According to Mark Fainaru-Wada and T.J. Quinn of ESPN.com, Brewers outfielder Ryan Braun has tested positive for a performance-enhancing drug.
Braun, who won the 2011 National League MVP Award, is disputing the result through arbitration. If it is upheld, he will face a 50-game suspension.
It should be noted that Major League Baseball has not once overturned the result of a PED test.
Here’s more from Fainaru-Wada and Quinn, who revealed the stunning news on Saturday evening as part of an “Outside the Lines” investigation:
The 28-year-old Braun had to provide a urine sample for testing during the playoffs, and he was notified of the positive test sometime in late October — about a month before he was named the National League’s most valuable player.
The positive result was triggered by elevated levels of testosterone in Braun’s system, the sources also told “Outside the Lines.” A subsequent, more comprehensive test revealed the testosterone was synthetic — not produced by Braun’s body.
Braun, 28, batted .332 with a .994 OPS, 33 home runs and 111 RBI in 150 games this year. He posted an .866 OPS and hit only 25 home runs in 2010, somewhat of a down season for the slugging left fielder.
The Brewers signed Braun to a five-year, $105 million contract extension in April, adding to a previous eight-year pact that he inked with Milwaukee in May of 2008. He’s under team control through 2021.
The Red Sox are expecting to go to an arbitration hearing with left-handed reliever Fernando Abad, per Pete Abraham of the Boston Globe. Red Sox president Dave Dombrowski said there was a “decent chance” a hearing would be necessary after countering Abad’s $2.7 million request with $2 million.
Abad, 31, pitched just 12 2/3 innings for Boston after the club acquired him from Minnesota at the trade deadline last season. The lefty earned a cumulative 3.66 ERA, 4.2 BB/9 and 7.9 SO/9 for the two teams in 2016. He received $1.25 million in 2016 and will remain under club control (through arbitration) in 2017. A $2.7 million salary would be a hefty increase for the veteran reliever, who has seen a significant decline since he put up a 1.57 ERA for the Athletics in 2014 and who has not amassed more than 0.6 fWAR in any single season to date.
While the Red Sox aren’t close to settling with Abad, Evan Drellich of the Boston Herald reports that they may be closing in on a settlement with left-handed starter Drew Pomeranz. Pomeranz filed at $5.7 million, while the Sox felt more comfortable at $3.6 million. The two are expected to meet somewhere in the middle to avoid an arbitration hearing later this winter.
The Braves reportedly have a deal in place with free agent catcher Kurt Suzuki, per Chris Cotillo of SB Nation. FOX Sports’ Ken Rosenthal adds that the contract is for one year, $1.5 million with up to $2.5 million in additional incentives.
Suzuki, 33, completed a three-year track with the Twins in 2016, slashing .258/.301/.403 with eight home runs in 373 PA. The veteran backstop likely won’t provide an offensive or defensive upgrade over current starter Tyler Flowers, but should give the Braves some depth at a position they’ve been looking to strengthen since the start of the offseason.
The team has yet to confirm the deal.